BFH three-lens brief
Evidence-based stock research on BFH. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
P/E of 7.7 — trading at a value multiple. · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- P/E of 7.7 — trading at a value multiple.
- Analyst mean target $114.88 — 18% above current (16 analysts).
BFH closed at $97.65 (+0.98%) as of 2026-11-12. Market cap: $3.71B. P/E (trailing) 7.7. Price is below the 50-day MA and above the 200-day MA. Positives: p/E of 7.7 — trading at a value multiple.; analyst mean target $114.88 — 18% above current (16 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.. Last quarter: Revenue $1.02B, net income $150.00M.
Why three lenses on BFH, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BFH across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/BFH" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BFH brief"></iframe>